Board / shareholder meeting outcomeFiled on BSE ·
Aarti Pharmalabs Limited announces results of 7th AGM held on September 22, 2026
Aarti Pharma · Pharmaceuticals & Biotechnology
What the filing says
- All resolutions proposed at the AGM were passed with requisite majority via e-voting and VC
- Key resolutions include appointment of Shri Rashesh C. Gogri as Managing Director from Oct 1, 2026
- Final dividend of ₹2 per equity share for FY ended March 31, 2026 was approved by shareholders
Original filing
Shareholder Meeting / Postal Ballot-Scrutinizer's Report
Read the filing on BSE (PDF) →Companies guiding to strong growth
Ranked by management's own guidance on revenue and margins — not by us.
Waaree Energies
Electrical Equipment
Revenue: Rank 1Margin: Rank 1
Sign up free to see all 6 →
See full rankingsRank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Other board / shareholder meeting outcome filings this fortnight
- Board / shareholder meeting outcomeTitan Biotech LtdTitan Biotech Limited holds 34th Annual General Meeting via video conferencing on Sept 29, 2026
- Board / shareholder meeting outcomeNLC India LtdNLC India Limited announces FY 2025-26 results and 70th AGM outcomes
- Board / shareholder meeting outcomeGrand Oak Canyons Distillery LtdGrand Oak Canyons Distillery Ltd announces voting results of 41st AGM held on 26 Sept 2026
- Board / shareholder meeting outcomeVasa DenticityVasa Denticity Limited holds 10th AGM via video conferencing on Sept 29, 2026
- Board / shareholder meeting outcomeManali Petrochemicals LtdManali Petrochemicals Limited holds 40th AGM, approves dividend and re-election
- Board / shareholder meeting outcomePatil Automation LtdPatil Automation Limited issues corrigendum to EGM notice revising allotment details
Summary written by Arthneeti from the company's filing with the stock exchange; check the original filing for full details. Arthneeti is a research and analytics platform, not a SEBI-registered investment adviser, and nothing here is a recommendation to buy or sell.